Author:
Gaitonde Puneet,Garhyan Parag,Link Catharina,Chien Jenny Y.,Trame Mirjam N.,Schmidt Stephan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference112 articles.
1. Schmidt S, Post TM, Boroujerdi M, Van Kesteren C, Ploeger B, Della Pasqua OE, et al. Disease progression analysis: towards mechanism-based models. In: Kimko HHC, Peck CC, editors. Clinical trial simulations—applications and trends. New York: Springer; 2010. p. 437–60.
2. Danhof M, Alvan G, Dahl SG, Kuhlmann J, Paintaud G. Mechanism-based pharmacokinetic–pharmacodynamic modeling—a new classification of biomarkers. Pharm Res. 2005;22(9):1432–7. doi: 10.1007/s11095-005-5882-3 .
3. Breimer DD, Danhof M. Relevance of the application of pharmacokinetic–pharmacodynamic modelling concepts in drug development: the “wooden shoe” paradigm. Clin Pharmacokinet. 1997;32(4):259–67. doi: 10.2165/00003088-199732040-00001 .
4. Danhof M, de Jongh J, De Lange EC, Della Pasqua O, Ploeger BA, Voskuyl RA. Mechanism-based pharmacokinetic–pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. Annu Rev Pharmacol Toxicol. 2007;47:357–400. doi: 10.1146/annurev.pharmtox.47.120505.105154 .
5. Miller R, Ewy W, Corrigan BW, Ouellet D, Hermann D, Kowalski KG, et al. How modeling and simulation have enhanced decision making in new drug development. J Pharmacokinet Pharmacodyn. 2005;32(2):185–97. doi: 10.1007/s10928-005-0074-7 .
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献